Trial Drug Shows Preliminary Promise Against Ovarian Cancer (HealthDay)

Your Health Matters

HealthDay – SUNDAY, Aug. 21 (HealthDay News) — An experimental drug that’s shown
promise against ovarian cancer caused by mutations in the BRCA1 or BRCA2
genes may also be effective against ovarian cancer not caused by those
gene mutations, according to a new study.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave